These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4060853)

  • 21. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
    Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies.
    Perrin P; Thibodeau L; Sureau P
    Vaccine; 1985 Sep; 3(3):325-32. PubMed ID: 4060842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses to influenza vaccines containing A/New Jersey/8/76.
    Feery BJ; Hampson AW; Rodda SJ; Evered MG
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):639-47. PubMed ID: 752306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.
    Johansson BE; Pokorny BA; Tiso VA
    Vaccine; 2002 Feb; 20(11-12):1670-4. PubMed ID: 11858877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
    Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
    Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus].
    Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM
    Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The subclass IgG responses of mice to influenza surface proteins formulated into liposomes.
    Ben Ahmeida ET; Jennings R; Tan L; Gregoriadis G; Potter CW
    Antiviral Res; 1993 Jul; 21(3):217-31. PubMed ID: 8215299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live bivalent vaccine for parainfluenza and influenza virus infections.
    Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y
    J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.
    Palache AM; Beyer WE; Lüchters G; Völker R; Sprenger MJ; Masurel N
    Vaccine; 1993; 11(9):892-908. PubMed ID: 8212834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.
    Johansson BE; Kilbourne ED
    J Infect Dis; 1990 Oct; 162(4):800-9. PubMed ID: 2401790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The specificity of serum antibodies to the haemagglutinin of influenza B viruses induced by vaccination.
    Creţescu L; Ioniţă E; Niculescu IT; Coban V; Bogdan C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):27-33. PubMed ID: 3324992
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of a zwitterionic detergent for the preparation of an influenza virus vaccine: 2. Immunogenicity of Empigen-treated virus in animals.
    Mukhlis FA; Crawford CR; Jennings R; Potter CW
    Vaccine; 1984 Sep; 2(3):199-203. PubMed ID: 6531962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus.
    Sarateanu DE; Ehrengut W; Pressler K; Peukert M; Schenk KD
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):225-36. PubMed ID: 7471712
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines.
    Pemberton RM; Jennings R; Smith TL
    J Hyg (Lond); 1985 Apr; 94(2):229-39. PubMed ID: 2580887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.